Sandoz’s High-Concentration Humira Biosimilar Lands On FDA’s Desk

SBLA Follows EMA Accepting Proposed Biosimilar For Filing In June

 
• By Dean Rudge
  
FDA website
Sandoz's filing is now with both the US and EU regulators • Source: Shutterstock

More from Biosimilars

More from Products